Design, Structural Inspection and Bio-Medicinal Applications of Some Novel Imine Metal Complexes Based on Acetylferrocene

Some novel imine metal chelates with Cr3+, Mn2+, Fe3+, Co2+, Ni2+, Cu2+, Zn2+, and Cd2+ cations were produced from 2-acetylferrocene and 3-aminophenol. The new acetylferrocene azomethine ligand ((Z)-cyclopenta-1,3-dien-1-yl(2-(1-((3-hydroxyphenyl)imino)ethyl)cyclopenta-2,4-dien-1-yl)iron) and its metal ion chelates were constructed and elucidated using FT-IR, UV/Vis, 1HNMR, DTA/TGA, CHNClM studies, mass spectrometry and SEM analysis. According to the TGA/DTG investigation, the ferrocene moiety spontaneously disintegrates to liberate FeO. The morphology of the free acetylferrocene azomethine via SEM analysis was net-shaped with a size of 64.73 nm, which differed in Cd(II) complex to be a spongy shape with a size of 42.43 nm. The quantum chemical features of the azomethine ligand (HL) were computed, and its electronic and molecular structure was refined theoretically. The investigated acetylferrocene imine ligand behaves as bidinetate ligand towards the cations under study to form octahedral geometries in case of all complexes except in case of Zn2+ is tetrahedral. Various microorganisms were used to investigate the anti-pathogenic effects of the free acetylferrocene azomethine ligand and its metal chelates. Moreover, the prepared ligand and its metal complexes were tested for anticancer activity utilizing four different concentrations against the human breast cancer cell line (MCF7) and the normal melanocyte cell line (HBF4). Furthermore, the binding of 3-aminophenol, 2-acetylferrocene, HL, Mn2+, Cu2+, and Cd2+ metal chelates to the receptor of breast cancer mutant oxidoreductase was discovered using molecular docking (PDB ID: 3HB5).


Introduction
Most transition metal ions can easily develop stable metal chelates with azomethine molecules, which is important in inorganic chemistry. The high stability potential of azomethine metal chelates with various oxidation states allowed these compounds to be used in a variety of applications [1][2][3][4]. Because of the broad range of coordination numbers and geometries of cationic metal ions, they provide opportunities for the development of therapeutic medicines [5]. These compounds were essential to the implementation of enzymatic processes, catalysis, and magnetism, as well as materials chemistry and molecular construction [6,7]. Due to their vital structural catalytic and magnetic characteristics, as well as their pharmaceutical applications, the synthesis and characterization of such metal

Molecular Structure
The Gaussian09 program suite was used to establish the ferrocene imine ligand's molecular structure and its CoHL complex [29]. They were completely refined using the LANL2DZ basis set and the DFT-based B3LYP approach. The TDDFT approach (together with the LANL2DZ basic set) was used to predict the electronic absorption spectra of the acetylferrocene azomethine ligand to evaluate the impact of the solvent on the molecule. The molecular orbital contribution to HOMO and LUMO was also computed.

Molecular Docking
Molecular docking manipulations were conducted utilizing MOE2008 software, which is a stiff molecular docking software, to determine the probable binding affinity of the most active drugs against the receptor of oxidoreductase mutation in breast cancer (3HB5) [30]. Docking is a molecular graphics tool that calculates and displays possible docking modes between a receptor and 3-aminophenol, 2-acetylferrocene, free ligand, Mn 2+ , Cu 2+ , and Cd 2+ chelates. These compounds, as well as the receptor, must be entered in PDB format. Water, co-crystallize ligands, ionization sphere (Cl), and other elements that are not supported (e.g., Na, K, Hg, etc.) were eliminated from the crystallization molecules [31]. Gaussian03 software was used to construct the structures of 2-acetylferrocene, 3-aminophenol, the free ligand, Mn 2+ , Cu 2+ , and Cd 2+ azomethine chelates in PDB file format. The database of proteins (http://www.rcsb.org./pdb, accessed on 1 January 2000) was used to retrieve the receptor of oxidoreductase mutation in breast cancer (3HB5).

Synthesis of Ferrocene Azomethine Metal Chelates
The Cr 3+ , Mn 2+ , Fe 3+ , Co 2+ , Ni 2+ , Cu 2+ , Zn 2+ , and Cd 2+ chelates were synthesized in combination with a 1:1 molar mixture of hot EtOH solution (70 • C) of chloride salts of the investigated cations (1.25 mmol; 0.33 g of CrCl 3 ·6H 2 O, 0.20 g of MnCl 2 ·2H 2 O, 0.20 g of FeCl 3 ·6H 2 O, 0.30 g of CoCl 2 ·6H 2 O, 0.30 g of NiCl 2 ·6H 2 O, 0.17 g of CuCl 2 ·2H 2 O, 0.17 g of ZnCl 2 and 0.23 g of CdCl 2 ) and the ligand (HL) (0.4 g, 1.25 mmol). The resultant mixture was agitated for 1 h under reflux, after which the metal chelates separated. They were extracted through filtering and purified by washing with a small amount of ethanol several times followed by Et 2 O multiple times. 1  The antimicrobial activities of the compounds under investigation were screened according to the Well diffusion approach [32][33][34]. The detailed method was shown in the supporting information file.

Optimization of Anticancer Study
The cytotoxicity of the prepared compounds against the MCF-7 cell line was investigated according to employed methods in the literature [33,35,36]. The detailed method was shown in the supporting information file.

Results and Discussions
3.1. Identification of the Acetylferrocene Azomethine Ligand and Its Metal Chelates 3.1.1. Elemental Analyses and Molar Conductivity Study Elemental analyses and some physical properties of the newly synthesized acetylferrocene azomethine ligand and its metal chelates were recorded in Table 1. The experimental data of elemental analyses were in agreement with the theoretical calculation from each compound's empirical formula. Acetylferrocene azomethine ligand was soluble in ethanol and its metal chelates were stable, nonhygroscopic, and soluble in most organic solvents such as DMF and DMSO and insoluble in ethanol, methanol and acetone. The molar conductivity values of metal chelate showed that all metal chelates were electrolytes except Cu 2+ , Zn 2+ , and Cd 2+ cations were non-electrolytes [37], indicating that no anions were located in the ionization sphere. The molar conductivity data for Fe 3+ and Ni 2+ chelates are close to those previously reported for 1:1 electrolytes [37,38]. In addition, Cr 3+ , Mn 2= and Co 2+ complexes have molar conductivity values close to 1:2 electrolytes.

FT-IR Spectral Studies
Several trials were carried out to prepare crystals suitable for X-ray analysis using single solvent or mixed solvents but unfortunately all trials were failed. Therefore, spectroscopic tools such as IR are significant and can help in describing the structures of the complexes.
The formation of acetylferrocene azomethine ligand (HL) was indicated by the inclusion of a sharp IR band at 1655 cm −1 owing to υ(C=N), while no bands ascribed to υ(C=O) or to υ(NH 2 ) had been recognized [1]. FT-IR spectral data of metal chelates were compared with the free acetylferrocene azomethine ligand (HL) shown in Table 2. The azomethine ligand showed a characteristic band of the OH group in the 3444 cm −1 regions [39]. The shift of this band to (3411-3446 cm −1 ) in the FT-IR spectra of the metal chelates ( Figure S1) cannot be assigned to the cations coordinated to the ligand via its phenolic OH. This shift can be also attributed to the presence of water molecules in the complex structures which render it difficult to confirm the coordination of the phenolic group. The band found at 1277 cm −1 in the IR spectrum of the azomethine ligand was assigned to υ(C-O) phenolic group [40]. The existence of this band at 1267-1283 cm −1 in the IR spectra of the complexes can account for the participation of phenolic oxygen in binding to the metal ions [40]. The shift of the C=N band to lower frequencies (1597-1649 cm −1 ) in the vibration spectra of the metal chelates compared to the acetylferrocene azomethine ligand suggested bonding of the imine nitrogen to the investigated cations [1,41]. Two weak bands in areas of 894-980 and 815-874 cm −1 attributable to (H 2 O) vibrations in the swinging and twisting modes, respectively, proved the presence of coordinated aqua molecules in all the metal chelates except Zn(II) acetylferrocene chelate [38]. The presence of coordinating water molecules was also inferred by the appearance of r(H 2 O) and w(H 2 O) vibrations, which were later determined by TGA analysis [42].
The new (M-O) and (M-N) weak intensity bands were assigned in the regions 520-598 cm −1 and 450-499 cm −1 , respectively [41]. This implies that phenolic oxygen and azomethine nitrogen were both involved in the formation of all chelates [43]. Based on the previous facts, it was determined that the acetylferrocene ligand acted as a neutral bidentate ligand as metal ions coordinated to phenolic oxygen and nitrogen of the azomethine group.

Mass Spectrometry
The mass spectra of the free ligand and its Co(II) complex are represented in Figure 1. The spectrum of the free ligand showed m/z peak at 319.02 amu with a relative intensity of 25%, which corresponds to the (C 18 H 17 NOFe) molecule. By matching molecular formula weight of 319.06 amu, which was in best accordance with this molecule, the predicted molecular formula of the investigated acetylferrocene azomethine ligand was confirmed. While the spectrum of [Co(HL)(H 2 O) 4 ]Cl 2 ·2H 2 O complex showed molecular ion peak at 552.13 amu which is highly agreed upon, the expected molecular weight (554 g/mol) that confirms this chelate formation. molecular formula of the investigated acetylferrocene azomethine ligand was confirmed. While the spectrum of [Co(HL)(H2O)4]Cl2·2H2O complex showed molecular ion peak at 552.13 amu which is highly agreed upon, the expected molecular weight (554 g/mol) that confirms this chelate formation.

1 H-NMR Spectroscopic Studies
Proof of the bonding type of the ligand was also confirmed by the 1 H-NMR spectra of the acetylferrocene azomethine ( Figure S2a) in DMSO and deuterated solvent and its diamagnetic Cd(II) acetylferrocene chelate ( Figure S2b). The titled Schiff base HL 1 H-NMR spectrum revealed a singlet signal at the downfield value at δ 8.78 ppm (s, 1H, phenolic OH) which is attributed to phenolic -OH proton and shifted to δ 8.71 ppm (s, 1H, phenolic OH) in the Cd(II) complex. With the addition of D2O, the OH signal vanished, confirming its assignment [44]. The detected signals of aromatic proton in the free acetylferrocene azomethine ligand in the region of δ 5.93-6.76 ppm (m, 4H, ArH) showed a small shift in the Cd(II) complex at δ 5.92-6.79 ppm (m, 4H, ArH), as a result of chelation-induced

1 H-NMR Spectroscopic Studies
Proof of the bonding type of the ligand was also confirmed by the 1 H-NMR spectra of the acetylferrocene azomethine ( Figure S2a) in DMSO and deuterated solvent and its diamagnetic Cd(II) acetylferrocene chelate ( Figure S2b). The titled Schiff base HL 1 H-NMR spectrum revealed a singlet signal at the downfield value at δ 8.78 ppm (s, 1H, phenolic OH) which is attributed to phenolic -OH proton and shifted to δ 8.71 ppm (s, 1H, phenolic OH) in the Cd(II) complex. With the addition of D 2 O, the OH signal vanished, confirming its assignment [44]. The detected signals of aromatic proton in the free acetylferrocene azomethine ligand in the region of δ 5.93-6.76 ppm (m, 4H, ArH) showed a small shift in the Cd(II) complex at δ 5.92-6.79 ppm (m, 4H, ArH), as a result of chelation-induced changes in electron density [45]. Moreover, the free Schiff base showed signals as δ 4.23-4.83 ppm and δ 3.33 ppm which were attributed to cyclopentadienyl (m, 9H, ferrocene) [46] and methyl (s, 3H, CH 3 ) [37] protons, respectively, that showed a slight shift to δ 4.23-4.77 ppm (m, 9H, ferrocene) and δ 3.23 ppm (s, 3H, CH 3 ), respectively, in the spectrum of the Cd(II) complex. The overall results of 1 H NMR studies confirmed the binding of metal ions to the free ligand through OH phenolic group without deprotonation, so it was concluded that our ligand was neutral bidentate with the general formula HL. The 13 C NMR spectrum of the acetylferrocene Schiff base ligand showed peaks at δ 18.2 ppm for CH 3

Geometrical Optimization of the Ligand and CoHL Complex
At the DFT level of theory, the full configuration of the free acetylferrocene azomethine ligand (HL) and its Co(II) complex was accomplished [44]. Figure S3 shows a perspective of the optimized structures of the HL and CoHL and their atom numbering. Table S1 show specified bond angles and distances of HL. The HL ligand shows distances (N2-C1) 1.30 Å, (N2-C3) 1.42 Å and (C6-O36) 1.40 Å. While in complexation, we observed stretching in these bonds to be (O22-Co) 1.71 Å, and (N7-Co) 1.59 Å (Table S2), respectively, which indicate the complexation through azomethine nitrogen and phenolic OH. Moreover, the Co(II) complex exhibited change in bond angles which confirm the complexation sites, HL shows angles C1-N2-C3 (125.78) and H37-O36-C6 (111.84). In CoHL complex, the angles which changed in Co(II) complex to be Co(21)-O(22)-C(3)56.14 and Co(21)-N(7)-C(1) 83.96 which confirming the chelation though azomethine nitrogen and phenolic OH. The major orbitals implicated in chemical consistency are the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO). The HOMO reflects the capacity to give an electron, whereas the LUMO as an electron acceptor reflects the ability to secure an electron. The HOMO and LUMO for the acetylferrocene azomethine ligand (HL) and its Co(II) complex were depicted in Figure 2. Table 3 lists the estimated quantum chemical factors. The Equations (1)-(8) below were used to derive further characteristics such as E, absolute electronegativities, chemical potentials, Pi, absolute hardness, absolute softness, global electrophilicity, global softness, S, and additional electronic charge, N max [47][48][49][50][51].
These calculated parameters showed that the free ligand was able to donate electrons to metal ions chelates with lower energy difference (3.75 eV), with ∆E of the free ligand (4.29 eV), so the Co(II) complex had high stability and high biological activities.

UV-Vis Absorption Investigations
The electronic spectrums of the free acetylferrocene azomethine ligand (10 −4 M) and its metal chelates (10 −5 M) were recorded in (1:3 v/v) ethanol: DMF in the range of 200-700 nm. HL's spectra comprised four major bands at 232, 268, 334, and 446 nm. The first two bands were allocated to n-π* transition of the benzene ring [3] which shifted to 233-290 nm in the metal chelates. The third band was attributed to π-π* transition of the imine group [52] which shifted to 302-366 nm in all-metal chelates except for Mn(II) and Ni(II) cation chelates, which disappeared. The fourth band was assigned to charge transfer transitions [52] from aromatic ring to imine group that disappeared in the metal chelates. Thermal decompositions were done under an air environment at a rate of heating 10 • C min −1 . The thermogravimetric data for the acetylferrocene azomethine (HL) and its metal chelates were depicted in Table 4 within the range of temperature of 30 to 1000 • C ( Figure S4a). The acetylferrocene azomethine ligand TG data revealed three steps of decomposition. The three stages took place between 35 and 695 • C (DTG maxima peaks temperatures at 198, 363, and 689 • C) and were associated with a loss of mass of 77.66% (loss of mass predicted = 77.31%) in agreement with the loss of the organic moiety of the ligand leaving iron(II) oxide residue.   3 Cl]Cl 2 ·3H 2 O chelate was thermally disintegrated in two conclusive decomposition steps. The two stages reported a found mass loss to be 9.17% (loss of mass predicted = 9.22%) and 51.11% (loss of mass predicted = 50.72%) within the range of temperature of 30-140 • C (DTG peak at 77 • C) and 140-1000 • C (DTG peak at 854 • C), which may be attributed to the disposal of three hydrated water molecules, three HCl molecules, one molecule of coordinated water, and C 11 H 18 ClNO 0.5 fragment ( Figure S5b). disposal of two hydrated water molecules and ammonia and methane gases (loss of mass found = 12.52%; loss of mass predicted = 12.40%) and two water molecules of hydration (loss of mass of 5.78%; predicted = 6.84%) for Co(II) and Cu(II) complexes, respectively. The 2nd and 3rd decomposition stages within the range of temperature of 190-1000 • C and 130-1000 • C correspond to the disposal of three coordinated water and C 13 H 12 Cl 2 molecules and C 11 H 19 NCl 2 and coordinated water molecules with a loss of mass of 51.94% (predicted = 52.65 %) and mass losses equated to 48.38% (predicted = 48.29%), for Co(II) and Cu(II) complexes, respectively. CoO and FeO and CuO and FeO residues with carbon contamination have remained. The cumulative amount of weight loss equates to 64.45% (predicted = 65.05%) and 54.15% (predicted = 55.13%) for Co(II) and Cu(II) complexes, respectively.
The TG curve of the Ni(II) chelate showed five stages of decomposition within the range of temperature of 35-1000 • C. The first stage at 35-145 • C (T s = 81 • C) matched with the disposal of two water molecules of hydration and ammonia gas, while the second step involved loss of HCl, CH 4 , and two coordinated water molecules within a range of temperature from 145 • C to 355 • C. The last three stages took place within the range 335-1000 • C and corresponded to the disposal of the C 11 H 11 Cl molecule with a reported loss of mass of 33.97% (predicted loss of mass = 33.09%) leaving carbon contaminated NiO and FeO residues with loss of mass 40.10% (predicted = 40.696%). The cumulative amount of weight loss was 59.90% (predicted = 59.31%).
The TG curve of Zn(II) and Cd(II) chelates revealed a peak at 77 • C and 185 • C in the range of temperatures 45-275 • C and 40-220 • C that was owing to a weight loss of 6.69% (predicted weight loss = 6.92%) and 27.68% (predicted = 27.86%), respectively. This stage could be assigned to the disposal of a hydrated water molecule and methane gas and two hydrochloride molecules, one coordinated water molecule, ammonia gas, and a C 3 H 6 fragment for Zn(II) and Cd(II) complexes, respectively. The final three decomposition stages took place at 275-1000 • C and 220-600 • C range of temperature with Ts = 402 • C, 585 • C, and 955 • C and 236 • C, 266 • C, and 519 • C were found to have the disposal of a mass of 54.88% (predicted loss of mass = 54.53%) and 35.18% (predicted mass loss = 34.91%) corresponding to the loss of ethene, two HCl and ammonia gas molecules and loss of C 15 H 8 fracture for Zn(II) and Cd(II) complexes, respectively ( Figure S5h,i). At the end of the curves, the ZnO and FeO were loaded with atoms of carbon, and CdO and FeO were the residues, with a total loss of weight equated to 61.56% (predicted = 61.44%) and 62.86% (predicted = 62.77%) ( Figure S5), for Zn(II) and Cd(II) complexes, respectively. The presence of carbon in the metallic residue was confirmed by dissolving the Al containing the residue in concentrated HCl solution where black residues were observed.

SEM
The surface morphology, structure, and size of the free acetylferrocene azomethine ligand and Cd(II) chelate were carried out using SEM images (Figure 3a,b). The SEM micrographs of the free ligand differed significantly from [Cd(HL)(H 2 O) 2 Cl 2 ] complex owing to the coordination of metal cation to the donor sites in the free acetylferrocene azomethine ligand [53,54]. The morphology of the free acetylferrocene azomethine was net-shaped with a size of 64.73 nm which differed in Cd(II) complex to be a spongy shape with a size of 42.43 nm. SEM analysis yielded a size distribution that indicated that the acetylferrocene azomethine ligand (HL) and the Cd(II) complex were polycrystalline with nanosized grains [53,55].

Structural Manipulation
According to the physicochemical and spectral facts supplied and addressed previously, metal chelate structures have been confirmed, and proposed structural formulas for metal chelates are illustrated in Figure 4.

Antimicrobial Activities
The examined compound's antibacterial activity was assessed in vitro against the microorganisms Aspergillus fumigatus and Candida albicans (fungi), Staphylococcus aureus, and Bacillus subtilis (G + ve bacteria), and Salmonella typhimurium and Escherichiacoli (G-ve bacteria) by the diffusion agar method. The inhibition zone diameter values of the tested samples were represented in Table S3 and Figure 5, indicating that the free ligand, Cr 3+ , Mn 2+ , Fe 3+ , and Ni 2+ metal chelates had no activity against some microorganisms, while other metal chelates showed some activity against some microorganisms, demonstrating the effect of chelation as the majority of metal chelates are more active than their respective azomethine ligand. In some cases, the free acetylferrocene azomethine ligand is more active than metal chelates against bacteria. Chelation either increases or decreases antibacterial activity; it can also be neutral. As a result, metal chelation may enhance or diminish the therapeutic effectiveness of organic molecules (drugs) [56][57][58]. By further stabilizing the medication and/or lowering the biodegradability/metabolic decay of the organic ligands through chelation, the characteristic may be preserved [59]. The activity indexes of the tested compounds were calculated and plotted in Figure S5a,b according to the following equation [60,61]:

Structural Manipulation
According to the physicochemical and spectral facts supplied and addressed previously, metal chelate structures have been confirmed, and proposed structural formulas for metal chelates are illustrated in Figure 4.

Antimicrobial Activities
The examined compound's antibacterial activity was assessed in vitro against the microorganisms Aspergillus fumigatus and Candida albicans (fungi), Staphylococcus aureus, and Bacillus subtilis (G + ve bacteria), and Salmonella typhimurium and Escherichiacoli (G-ve bacteria) by the diffusion agar method. The inhibition zone diameter values of the tested samples were represented in Table S3 and Figure 5, indicating that the free ligand, Cr 3+ , Mn 2+ , Fe 3+ , and Ni 2+ metal chelates had no activity against some microorganisms, while other metal chelates showed some activity against some microorganisms, demonstrating the effect of chelation as the majority of metal chelates are more active than their respective azomethine ligand. In some cases, the free acetylferrocene azomethine ligand is more active than metal chelates against bacteria. Chelation either increases or decreases antibacterial activity; it can also be neutral. As a result, metal chelation may enhance or diminish the therapeutic effectiveness of organic molecules (drugs) [56][57][58]. By further stabilizing the medication and/or lowering the biodegradability/metabolic decay of the organic ligands through chelation, the characteristic may be preserved [59]. The activity indexes of the tested compounds were calculated and plotted in Figure S5a,b according to the following equation [60,61]: The Cd(II) complex exhibited the greatest activity index, according to the findings (100 percent). The discrepancies in metal chelate action against microbial species are related to variances in microbial cell ribosomes or cell impermeability. The lower activity of complexes in comparison to others could be due to low lipid solubility, which prevents the metal ion from reaching the cell wall's preferred location of action and disrupting normal cell function. Other variables such as solubility, size, dipole moment, coordinating sites, the redox potential of metal ions, solubility, the bond length between metal and ligand, geometry of complexes, steric, pharmacokinetic, concentration, and hydrophobicity also play a role in evaluating the antibacterial activity of metal chelates [62]. The Cd(II) complex exhibited the greatest activity index, according to the findings (100 percent).
The discrepancies in metal chelate action against microbial species are related to variances in microbial cell ribosomes or cell impermeability. The lower activity of complexes in comparison to others could be due to low lipid solubility, which prevents the metal ion from reaching the cell wall's preferred location of action and disrupting normal cell function. Other variables such as solubility, size, dipole moment, coordinating sites, the redox potential of metal ions, solubility, the bond length between metal and ligand, geometry of complexes, steric, pharmacokinetic, concentration, and hydrophobicity also play a role in evaluating the antibacterial activity of metal chelates [62].

Anticancer Activities
Chemotherapy is the most common treatment option for both localized and metastatic cancer [63]. Therefore, the investigated compounds were screened for their in vitro growth inhibitory and cytotoxicity activities against breast cancer cell line.
Antitumor efficiency of the free acetylferrocene azomethine ligand (HL) and its metal chelates was screened against breast cancer cell line (MCF7) and normal melanocyte cell line (HBF4) in high concentration (100 µg/mL).
The cytotoxicity of the compounds studied was measured using the median antiproliferative concentration (IC 50 ), which required the compounds to have a 50% cytotoxic effect on cancer cells after 48 h of exposure.
Only Mn(II), Cu(II) and Cd(II) metal chelates showed an inhibitory effect >70% against the MCF7 cell line, so they were carried out in four different concentrations; the findings were shown in Table S4 and demonstrated in Figure 6.

Molecular Docking
The uncontrolled proliferation of aberrant cells is referred to as cancer. Breast cancer and lung cancer were the most frequently diagnosed fatal cancers in women over the world, with significant mortality rates. Breast cancer is predicted to affect more than 90,000 Indian women in the next years, with over 50,000 women dying each year [63]. Computer drug design highly depends on molecular docking [65]. The objective of molecular docking is to mimic the process of molecular recognition. It is also necessary to identify an appropriate shape for both the protein and the drug, with their positions relative to one another, in order to lower the overall system's free energy.
The molecular docking of starting materials 3-aminophenol and 2-acetylferrocene, the free acetylferrocene azomethine ligand HL, Mn(II), Cu(II), and Cd(II) metal chelates was carried out with the receptor of breast cancer (2HB5). The docking investigation revealed a significant interaction between these drugs and the receptor (3HB5), as well as a low binding energy calculation, which was recorded in Table S5 and Figure 7 demonstrating 3D structures of possible interactions.
According to our data, it was found that binding energies can be ordered ascendingly as follows: 3-aminophenol (−3.3 kcal/mol) < 2-acetylferrocene (−6.2 kcal/mol) < HL (−10 kcal/mol) < Cu(II) complex (−20.4 kcal/mol) < Mn(II) complex (−62.3 kcal/mol)< Cd(II) The order of cytotoxicity activity against the two cancer cell lines of the investigated chemicals is obvious from the data; it was Cd(II) > Cu(II) > Mn(II) complex. The highest activity of the Cd(II) complex than the others may be attributed to the function of the Cd(II) chelate as a competitive inhibitor of hemeoxygenase (HMOX1), which is produced in large amounts in solid tumors [64], in humans and animal tumor models.

Molecular Docking
The uncontrolled proliferation of aberrant cells is referred to as cancer. Breast cancer and lung cancer were the most frequently diagnosed fatal cancers in women over the world, with significant mortality rates. Breast cancer is predicted to affect more than 90,000 Indian women in the next years, with over 50,000 women dying each year [63]. Computer drug design highly depends on molecular docking [65]. The objective of molecular docking is to mimic the process of molecular recognition. It is also necessary to identify an appropriate shape for both the protein and the drug, with their positions relative to one another, in order to lower the overall system's free energy.
The molecular docking of starting materials 3-aminophenol and 2-acetylferrocene, the free acetylferrocene azomethine ligand HL, Mn(II), Cu(II), and Cd(II) metal chelates was carried out with the receptor of breast cancer (2HB5). The docking investigation revealed a significant interaction between these drugs and the receptor (3HB5), as well as a low binding energy calculation, which was recorded in Table S5 and Figure 7 demonstrating 3D structures of possible interactions. lecular docking is to mimic the process of molecular recognition. It is also necessary to identify an appropriate shape for both the protein and the drug, with their positions relative to one another, in order to lower the overall system's free energy.
The molecular docking of starting materials 3-aminophenol and 2-acetylferrocene, the free acetylferrocene azomethine ligand HL, Mn(II), Cu(II), and Cd(II) metal chelates was carried out with the receptor of breast cancer (2HB5). The docking investigation revealed a significant interaction between these drugs and the receptor (3HB5), as well as a low binding energy calculation, which was recorded in Table S5 and Figure 7 demonstrating 3D structures of possible interactions.

Conclusions
The chemical structures of a novel free acetylferrocene azomethine ligand (HL) and the coordination chemistry of some transition metal cations-Cr 3+ , Fe 3+ , Mn 2+ , Co 2+ , Ni 2+ , Cu 2+ , Cd 2+ , and Zn 2+ cations-with the newly synthesized ligand were elucidated using various physicochemical techniques as molar conductance proved the electrolytic nature of metal chelates by showing that all metal chelates were electrolytes, except Cu(II), Zn(II) and Cd(II) metal chelates could not conduct electricity in their solutions. IR studies showed that the free ligand acted as a neutral bidentate ligand as metal ions coordinated with phenolic oxygen and nitrogen of the imine group. 1 HNMR analysis confirmed that complexation took place without deprotonation of the phenolic OH group. From geometrical calculations, the calculated parameters showed that the free ligand was able to donate electrons to metal ions forming stable metal chelates. From SEM studies, it was found that the free acetylferrocene azomethine ligand and its Cd(II) chelate were in nano size. Mn(II) complex only demonstrated IC 50 Table S1: The different optimized parameters of the free Schiff base ligand; Table S2: The bond lengths and angles of CoHL complex; Table S3: Biological activity of organometallic Schiff base (HL) and its metal complexes; Table S4: Anticancer activity of Schiff base ligand and its metal complexes; Table S5: Energy values obtained in docking calculations with the receptors of (3hb5); Figure S1: FT-IR spectra of (a) HL, (b) Cr(III), (c) Mn(II), (d) Fe(III), (e) Co(II), (f) Ni(II), (g) Cu(II), (h) Zn(II) and (i) Cd(II) complexes; Figure S2: Mass spectrometry of the free acetyl ferrocene azomethine ligand; Figure S3: 1HNMR spectra of (a) HL and (b) its Cd(II) complex Figure S4: The optimized structure of the newly synthesized (A) Schiff base HL and its (B) CoHL complex; Figure   Data Availability Statement: The raw/processed data generated in this work are available upon request from the corresponding author.